Volume III, Issue IV - October 2021 Newsletter

Welcome New SUPR Staff

Jamelia Hand, Deputy Director

Jamelia Hand, MHS CADC CODP has joined the SUPR team as the Deputy Director of the Bureau of Licensure, Compliance and Monitoring.

Thelma Davis

Thelma Davis has joined the SUPR team as an Administrative Assistant in the Bureau of Business and Fiscal Operations.

Dana Careless, Behavioral Health Advisor

Dana Careless has joined the SUPR team as the Behavioral Health Advisor in the office of the Director.

We are excited to welcome new members to our SUPR family!

IDHS/SUPR Trainings

The Illinois Department of Human Services/Division of Substance Use Prevention and Recovery (IDHS/SUPR) invites you to participate in IDHS/SUPR sponsored trainings.

IDHS/SUPR is pleased to announce the second quarter training opportunities for treatment organizations, including opioid treatment programs and recovery homes!

To learn more about the training offerings, please review the attached training calendar for descriptions, date(s), and time(s) for each training. We have also included "Instructions for Registering for IDHS/SUPR Trainings" that outlines how to register for the trainings.

Please note that Prevention First coordinates these trainings.

Access Narcan Program

The Illinois Department of Human Services/Division of Substance Use Prevention and Recovery (IDHS/SUPR) aims to reduce the number of opioid overdoses through the expansion of community-based Overdose Education and Naloxone Distribution (OEND) services.

IDHS/SUPR manages the Drug Overdose Prevention Program (DOPP), the state's overdose prevention program, as authorized by the Substance Use Disorder Act ((20 ILCS 301/). Organizations that are currently enrolled and new DOPP enrollees will be provided with access to directly order Narcan (naloxone nasal spray) at no cost to the organizations.

For additional details and information on how to register, visit our Smart Alert that was published in August!

Strategic Prevention Framework Rx Grant

The Illinois Department of Human Services/ Division of Substance Use Prevention and Recovery (IDHS/SUPR) have been granted the Strategic Prevention Framework Rx grant! We will be working with Midwestern University as well as the Prescription Monitoring Program (PMP) to provide prevention awareness activities in selected high schools.

Communities and high schools will be chosen by PMP data that identify areas where prescription drug prescribing for emerging adults is high. We are looking forward to a great project with exceptional partners!

SUPR/Bureau of Prevention Services (BPS) Budget Revisions

October is here which means it is budget revision request time for grantees of BPS. Please keep in mind that you will need to include the completed Budget template (attached) in the request and a small explanation in the narrative sections regarding the reason for the specific category/line item adjustment.

If you need to revise your SFY22 approved budget, please reach out to your Project Director or Administrator.

Illinois Preventing Drug Overdose (IPDO) Project

The Illinois Preventing Drug Overdose (IPDO) project was granted a No Cost Extension that started effective September 1st, 2021. This will allow IPDO activities to continue serving the counties of Cook, DuPage, Lake, Will, Monroe, and St. Claire. The Bureau of Prevention Services will be reaching out to grantees regarding requests to continue funding pending projects.

Increases in Availability of Cannabis Products Containing Delta-8 THC

This highlight is from the CDC Health Alert Network CDCHAN-00451.

There is an increased availability of cannabis products containing delta-8 tetrahydrocannabinol (THC) and the potential for adverse events due to insufficient labeling of products containing THC and cannabidiol (CBD).

From January 1 to July 31, 2021, after The American Association of Poison Control Centers (AAPCC) introduced a product code specific to delta-8 THC into its National Poison Data System (NPDS), 660 delta-8 THC exposures were recorded with the new product code, and one additional case was recoded as a delta-8 THC exposure from October 2020.

Eighteen percent of exposures (119 of 661 cases) required hospitalization, and 39% (258 of 661 cases) involved pediatric patients less than 18 years of age. Delta-8 THC intoxication can cause adverse effects similar to those observed during delta-9 THC intoxication, and may include lethargy, uncoordinated movements and decreased psychomotor activity, slurred speech, increased heart rate progressing to slowed heart rate, low blood pressure, difficulty breathing, sedation, coma.

Consumer recommendations include:

  • Consumers should be aware of possible limitations in the labeling of products containing THC and CBD even from approved marijuana and hemp retailers. Products reporting only delta-9 THC concentration, but not total THC may underestimate the psychoactive potential for consumers.
  • Consumers should be aware that products labeled as hemp or CBD may contain delta-8 THC, and that products containing delta-8 THC can result in psychoactive effects. Consumers may have a false sense of safety, as delta-8 THC products may be labeled as hemp or CBD, which consumers may not associate with psychoactive ingredients.
  • Parents who consume edibles and other products that contain THC and CBD should store them safely away from children.
  • If consumers experience adverse effects of THC- or CBD-containing products that are an immediate danger to their health, they should call their local or regional poison control center at 1- 800-222-1222 or 911 or seek medical attention at their local emergency room and report the ingredients of ingested products to healthcare providers. Consumers are also encouraged to report adverse events to MedWatch.
  • Consumers should be aware that the cannabis marketplace continues to evolve. Other cannabis - derived products of potential concern have emerged recently, such as those containing delta-10 THC and THC-O acetate. More research is needed to understand the health effects of products containing these compounds.

COVID-19 Exceptions

A gentle reminder that COVID-19 exceptions are still in effect and have no expiration date currently. Services delivered through Telehealth are still acceptable.

Please review the Provider Notice from the Illinois Department of Healthcare and Family Services (HFS) dated March 20, 2020, "Telehealth Services Expansion Prompted by COVID-19"

IDHS/SUPR has also sent several communications regarding the COVID-19 Exception that you can review.

Recovery Residences Registry

The IDHS/SUPR Recovery Residence Registry has been moved to the Illinois Helpline for Opioids and Other Substances to streamline searches, rather than looking in a separate place for recovery residence information. Information in the registry helps IDHS/SUPR better understand recovery residences' capacity and support for Medication Assisted Recovery. If you partner with a residence that is not listed, please invite them to register and/or contact Kimberly.Sriner@illinois.gov to list the organization. Search the Recovery Residences Registry at any time.

Overdose Response Funding Updates

SUPR publishes a monthly report summarizing funded projects in response to the overdose crisis. We invite you to review the Overdose Response Funding Report at your convenience.

Smart Alerts and Other Communications

DHS Coronavirus

SAMHSA COVID-19:  The health, safety, and well-being of all those we serve are amongst our highest priorities. Please visit the State of Illinois Coronavirus page.

Summary of SUPR Resources During the COVID-19 Pandemic

Smart Alerts

SUPR COVID-19 Communications

FY 2021 IDHS/SUPR Training Calendar - 2nd Quarter (October - December 2021)

Trainings Schedule

American Society of Addiction Medicine (ASAM) Criteria:  2-DaySkill Building Training

Target Audience: Counselors and Clinical Supervisors

This two-day, application-focused training provides participants with an in-depth look at the theoretical foundations of the Criteria, including clinically- driven services, biopsychosocial assessment, the six dimensions, continued stay and transfer/discharge criteria. Incorporating the use of the new edition of The ASAM Criteria book, participants have opportunities for skill practice at every stage of the treatment process: assessment, engagement, treatment planning, continuing care and transfer or discharge.

ASAM Criteria

October 19-20, 2021

American Society of Addiction Medicine (ASAM) Criteria Implementation

Leader: 3-Day Training

Target Audience: Clinical Supervisors and Administrative/Leadership Staff

This training is learning about processes and models for assessing the field, the equipment and what needs to change to support the new model. As leaders in their communities and their programs, in addition to their clinical knowledge, Implementation Leaders are the "foot soldiers" for The ASAM Criteria implementation process. Implementation Leaders develop awareness about thoughtful planning, communication and

appropriate system change strategies to drive implementation and sustainability, as well as coaching and supervising others on the Criteria.

*Two-day ASAM Criteria Skill Building training is a prerequisite.

  • Each participant receives 2 hours of coaching calls post training.
  • All participants receive an in-depth training journal to guide the training experience and as a resource for continuing skill application, as part of the training.

ASAM Criteria Implementation Leader

November 30-December 2, 2021

Harm Reduction Approach within ASAM Criteria Framework:  1-Day

The ASAM Criteria provides guidelines focusing on coordinating medical care, providing therapeutic alternatives, evaluating safety, addressing co-occurring disorders, involving social supports, and documenting clinical needs within the framework of the six dimensions. This includes setting and evaluating individualized measurable treatment goals which drive variable lengths of stay based on the needs of the person served. The Criteria centers on the clinically indicated intensity of care based on an ongoing assessment, determining progress based on the individualized plan of care, making appropriate referrals and recommendations, and providing adequate social support referrals when needed. This training provides skill building in the use of the ASAM Criteria as a framework for determining the most appropriate intensity of services and how a harm reduction model/approach; specifically providing strategies for working with clients on goal setting, application of risk reduction skills and evaluation of treatment goals fits within the broader framework of the Criteria's six dimensions and levels of care.

Harm Reduction Approach

October 29, 2021

Medications in Treatment: 1-Day

One of the challenges of Medications in Treatment (MAT) is that clients and counselors often focus on the medication and lose the balance of full recovery. This M.D. level facilitated workshop will focus on how to use the evidence-based practices of motivational interviewing cognitive behavioral therapy, and the trans-theoretical model of behavior change to broaden substance use disorder treatment beyond the "bio" (as in biopsychosocial) administration of the medication. It will help providers collaborate with clients to individualize substance use treatment and develop person-centered services that hold clients accountable and attract them to recovery.

Medications in Treatment

October 26, 2021

Co-occurring Disorders Program Curriculum Training:  Virtual Trainings on Co-occurring Disorders Program

Target Audience: Mental health, substance use and co-occurring disorder counseling and clinical staff; during portions of the training we strongly encourage attendance from administrative and clinical leadership, intake/registration, and quality and compliance departments

The goal of the counselor implementation training is to help clinicians apply the evidence-based programs in the Co-Occurring Disorders Program to deliver the best possible services to persons with co- occurring substance use and mental health disorders.

As a result of this training, participants will be able to:

  • use protocol-driven screening methods that consider eachpatient's symptoms, history, and motivation to change
  • combine Motivational Enhancement Therapy (MET), Cognitive-

Behavioral Therapy (CBT), and Twelve Step Facilitation (TSF) toengage, assist, and sustain change

  • use CBT to address common psychiatric problems, such asdepression, anxiety, PTSD and others
  • convey vital and current information on medication compliance, stigma, and other psychopharmacological issues
  • understand program philosophy and clinical principles in the family program component of the CDP
  • apply CDP to a variety of clinical situations

Screening and Assessment and Medication Management

October 14, 2021

Integrating Combined Therapies Curriculum

October 18, 2021
Cognitive Behavioral Therapy Curriculum

October 28, 2021

Family Program Curriculum

November 12, 2021

Intro to Cultural Humility

Cultural humility is the lifelong process of learning, self-examination & refining of one's own awareness, knowledge, behavior, and attitudes on the interplay of power, privilege and social contexts. Cultural humility is a more accurate representation of the process of constant reflection and change that takes place when learning about the ever-changing culture.

Intro to Cultural Humility

November 12, 2021

Leadership Development

This workshop will explore the components needed to build a culture of serving others first and exploring one's identity and relationship with their emotions. Through interactive discussions about emotional maturity, leadership development and appropriate use of ones' experience to advocate for change, participants will walk away with an increased ability to build a thriving community culture.

  • Understand and apply servant leadership values & competencies
  • Develop servant leadership / EQ evaluation for staff and clients

Leadership Development

November 12, 2021

Instructions for Registering for IDHS/SUPR Trainings

You will find the registration information for each training in the training calendar and on the Prevention First website.

As a reminder, before you register, you must create an account with Prevention First unless you have already established one. If you have an account, please review instructions for registering.

Instructions for setting up an account

  • go to Prevention First
  • on the right side of page, click on LOG IN OR REGISTER
  • click on NEW USER? REGISTER
  • complete the account information

To register for a training from the calendar, click on the link in the calendar and following the instructions below:

  • click on the link
  • click on "register for this event"
  • Follow the prompts to log into your account
  • Once logged in, click "general registration," and click "register me"

To register for trainings from the website, following the instructions below:

  • go to Prevention First
  • on the right side of page, click on LOG IN OR REGISTER
  • enter your username and password
  • hover over TRAINING across top of page
  • scroll down to training of interest
  • click on the date you would like to register for and follow the prompts

After you register for the training, you will receive a confirmation email with a link. You may also need to complete the webinar registration to receive your webinar login information.